Blood pressure medication could prevent Parkinson’s

News

Author: Simge Eva DoganPublished: 2 May 2019

Prep: Cook: Serves:

Scientists in the UK and China have found that a drug used to treat high blood pressure may be able to halt the development of Parkinson’s.

As part of the study – published in science journal ‘Nature Communications’ – zebrafish and mice were genetically altered to develop Parkinson’s and other neurodegenerative conditions. The scientists then administered the animals with drug concentrations similar to those suitable for humans.

The results showed that the drug prompted autophagy, a process which removes toxic proteins from brain cells – it also helped to reduce the damage caused by the toxic proteins.

David C. Rubinsztein, professor of molecular neurogenetics at the University of Cambridge, UK, and study author, said: “This is the first time that we’re aware of that a study has shown that an approved drug can slow the build-up of harmful proteins in the brains of mice using doses aiming to mimic the concentrations of the drug seen in humans.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.

Groundbreaking Parkinson’s trial publishes results

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

Parkinson’s Sidekicks: bridging the intergenerational gap

A US art initiative tackling social isolation in Parkinson’s

Climbing Machu Picchu to conquer Parkinson’s

Trekkers with Parkinson’s raise $120,000 for stem cell study

“Friendships are more powerful than any border”

Israel-based blogger Debbie Shapiro shares her diary from WPC 2019

Study suggests why neurons die in Parkinson’s disease

Researchers at the University of Córdoba, Spain, have discovered how a certain protein may be linked to death of dopamine-producing neurons associated with Parkinson’s. Using animal models of the condition to conduct their study, the team focused on the protein DJ-1 – whose link to Parkinson’s has previously been established, though its exact function was uncertain. The researchers compared neurons in the brains of mice that possessed the gene expressing DJ-1 with those that did not. The findings revealed that dysfunction or absence of the gene expressing the DJ-1 protein could trigger the ‘cell cycle’ (the process by which cells divide), which should not occur under normal conditions. Because neurons lack the capacity to divide, this causes them die – leading to the onset of symptoms linked with Parkinson’s. It is hoped that uncovering these details about the relationship between DJ-1’s absence and Parkinson’s may lead to the development of…

Researchers have finally identified brain cells linked to Parkinson’s disease

For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Blood pressure medication could prevent Parkinson’s

News

Author: Simge Eva DoganPublished: 2 May 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

Parkinson’s Sidekicks: bridging the intergenerational gap

Global update

Climbing Machu Picchu to conquer Parkinson’s

Global update

“Friendships are more powerful than any border”

Study suggests why neurons die in Parkinson’s disease

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

{title}

Subscribe

Blood pressure medication could prevent Parkinson’s

News

Author: Simge Eva DoganPublished: 2 May 2019

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

Parkinson’s Sidekicks: bridging the intergenerational gap

Global update

Climbing Machu Picchu to conquer Parkinson’s

Global update

“Friendships are more powerful than any border”

Study suggests why neurons die in Parkinson’s disease

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

{title}

Subscribe

Sign in